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Pathways to nephron loss starting from glomerular diseases—
Insights from animal models.
Studies of glomerular diseases in animal models show that
progression toward nephron loss starts with extracapillary le-
sions, whereby podocytes play the central role. If injuries remain
bound within the endocapillary compartment, they will undergo
recovery or be repaired by scaring.
Degenerative, inflammatory and dysregulative mechanisms
leading to nephron loss are distinguished. In addition to several
other unique features, the dysregulative mechanisms leading to
collapsing glomerulopathy are particular in that glomeruli and
tubules are affected in parallel. In contrast, in degenerative and
inflammatory diseases, tubular injury is secondary to glomerular
lesions. In both of the latter groups of diseases, the progression
starts in the glomerulus with the loss of the separation between
the tuft and Bowman’s capsule by forming cell bridges (parietal
cells and/or podocytes) between the glomerular and the parietal
basement membranes. Cell bridges develop into tuft adhesions
to Bowman’s capsule, which initiate the formation of crescents,
either by misdirected filtration (proteinaceous crescents) or by
epithelial cell proliferation (cellular crescents). Crescents may
spread over the entire circumference of the glomerulus and, via
the glomerulotubular junction, may extend onto the tubule.
Two mechanisms concerning the transfer of a glomerular in-
jury onto the tubulointerstitium are discussed: (1) direct en-
croachment of extracapillary lesions and (2) protein leakage
into tubular urine, resulting in injury to the tubule and the in-
terstitium. There is evidence that direct encroachment is the
crucial mechanism.
Progression of chronic renal disease is underlain by a vicious
cycle which passes on the damage from lost and/or damaged
nephrons to so far healthy nephrons. Presently, two mechanisms
are discussed: (1) the loss of nephrons leads to compensatory
mechanisms in the remaining nephrons (glomerular hyperten-
sion, hyperfiltration, hypertrophy) which increase their vulner-
ability to any further challenge (overload hypothesis); and (2) a
proteinuric glomerular disease leads, by some way or another, to
tubulointerstitial inflammation and fibrosis, accounting for the
further deterioration of renal function (fibrosis hypothesis). So
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far, no convincing evidence has been published that in primary
glomerular diseases fibrosis is harmful to healthy nephrons.
The potential of glomerular injuries to regenerate or to be
repaired by scaring is limited. The only option for extracapillary
injuries with tuft adhesion is repair by formation of a segmental
adherent scar (i.e., segmental glomerulosclerosis).
The decline in renal function in chronic renal failure
is caused by the progressive loss of viable nephrons. Sur-
prisingly few studies have dealt with the question of how
a nephron undergoes irreversible degeneration during a
specific kidney disease. It is widely believed that excessive
matrix production, either in the glomerular mesangium
or the tubulointerstitium, plays a crucial role. However,
the evidence for such a mechanism is entirely correlative
in nature; a causal relationship, in our view, has never
been established.
In humans and in laboratory animals, the majority of
diseases which progress to chronic renal failure start at
the glomerulus. This review will deal with pathways of
progression of a primary glomerular disease to complete
nephron degeneration. Pathway is defined here as a series
of consecutive and causally related events starting with a
healthy nephron and ending with its loss.
We will mainly present insights from animal models.
Though there are fundamental consistencies and ample
similarity in details with glomerular diseases in humans,
we will, in general, not expressly mention the latter; this
would break up the frame of this review. We have ex-
cluded, first, the diseases beginning at preglomerular ves-
sels (i.e., all kinds of vaso-occlusive diseases leading to
ischemic events downstream) and, second, the diseases
which begin within the interstitium (primary interstitial
diseases) or with direct damage to the tubule (by toxic,
ischemic and/or obstructive mechanisms).
GLOMERULAR DISEASES
Glomerular diseases comprise a large variety of indi-
vidual entities. Our working hypothesis is that all these
primary diseases converge into few pathways of disease
progression.
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When talking about glomerular pathomechanisms, it
is most useful to distinguish between the endocapil-
lary compartment, which consists of the capillaries and
the mesangium and, separated by the glomerular base-
ment membrane (GBM), the extracapillary compart-
ment, which consists of podocytes, Bowman’s space and
Bowman’s capsule. The latter comprises the parietal ep-
ithelium and the parietal basement membrane (PBM).
Basically, the endocapillary compartment is a capillary
network with surrounding mesangial cells; thus it comes
without surprise that pathological processes share many
features with those in other capillary beds (e.g., inflam-
matory processes, wound healing). In contrast, the extra-
capillary compartment is unique and absolutely specific
to the glomerulus; this holds true for the pathologic de-
velopments in this compartment.
As long as a glomerular disease remains restricted to
the endocapillary compartment, it is subject to restitu-
tion or repair even if the lesions are massive (see below).
According to what is seen in animal models, progres-
sion of a glomerular disease starts with the involvement
of the extracapillary compartment. Every extracapillary
process interferes with the filtration barrier and the sep-
aration between the tuft and Bowman’s capsule, leading,
in general locally by forming a tuft adhesion to Bow-
man’s capsule, to the obliteration of Bowman’s space.
Summarized in a synopsis (Fig. 1), three different mech-
anisms may be distinguished as being responsible for the
progression of a glomerular disease toward nephron loss.
These are degenerative, inflammatory, and, dysregulative
mechanisms; essential structural features are depicted in
Figure 2.
These three mechanisms represent prototypes of dam-
age development in the glomerulus. In an actual case (as
will be discussed later in more detail) they may well be
mixed. For instance, a “cellular lesion” (known in human
pathology as a dense assembly of podocytes on the surface
of an injured tuft portion; [27]), in our view, represents
a local manifestation of the dysregulative pathway that
may well be encountered in a predominantly degenera-
tive glomerular disease.
Dysregulative mechanisms
The dysregulative mechanisms are clearly different
from both others, the degenerative and inflammatory
ones. The unique histologic pattern, now named col-
lapsing glomerulopathy, is most frequently encountered
in patients with human immunodeficiency virus (HIV)
nephropathy, but idiopathic cases occur as well [28, 29]. It
is debated whether the “cellular lesion” in focal segmen-
tal glomerulosclerosis (FSGS) belongs to the spectrum
of collapsing glomerulopathy or represents yet another
variant of FSGS [28–31]. Transgenic models (see Fig. 1)
exhibiting a strikingly similar histopathology have led to
Fig. 1. Progression of extracapillary injuries.
insights into mechanisms leading to this lesion. The dys-
regulative pathway may be summarized as follows [1–3,
8, 32–34]. HIV infection or some other so far unknown
intracellular event cause regulatory defects in glomeru-
lar and tubular epithelial cells. In the glomerulus, dys-
regulation of podocytes leads to the loss of the specific
cell shape and to uncontrolled proliferation [33, 35]. The
now cuboidal cells display many features of immature
podocytes during nephrogenesis. These dedifferentiated
cells fill Bowman’s space and form “pseudocrescents.”
Furthermore, a defect in the regulation of vascular en-
dothelial growth factor (VEGF) synthesis by podocytes
406 Kriz and LeHir: Pathways to nephron loss
Fig. 2. Esssential structural features of the dysregulative (A), the degenerative (B), and the inflammatory (C) pathway to nephron degeneration. The
glomerular basement membrane (GBM) is shown in black, mesangial cells in a bird-feet pattern, podocytes are densely stippled, and macrophages
are loosely stippled. Parietal cells are shown in dark brown, proximal tubule cells in pale brown, and fibroblasts in green. Abnormal filtrate spreading
is indicated in yellow. See text for further explanation.
[7, 36] results in endothelial damage followed by the
collapse of glomerular capillaries, and ultimately of an
entire lobule or even the entire tuft. In tubules the regu-
lative defects lead to false sorting of membrane proteins
and progressive formation of microcysts [2, 3], resulting
in tubular degeneration and tubulointerstitial injury with
final destruction of the entire cortex. Congenital diseases
in humans exhibiting this kind of nephron degeneration
(e.g., Denys-Drash syndrome) have long been known;
they are based on mutations in the Wilms’ tumor gene
[37, 38].
Degenerative mechanisms
The degenerative and the inflammatory mechanisms
share several important histopathologic features; in par-
ticular both lead to crescent formation as the crucial step
to nephron loss. In the degenerative models (see Fig. 1),
apart from the toxic models, podocytes are exposed to
persistent long-term challenges, including glomerular hy-
pertension, metabolic disturbances as well as abnormal
receptor stimulation either by growth factors or vasoac-
tive compounds. Functionally, these challenges account
for the loss of size selectivity of the glomerular bar-
rier, leading to excessive protein leakage into tubular
urine. Structurally, in addition to hypertrophy, a stereo-
typed pattern of lesions are encountered (foot process
effacement as the most common lesion, cell-body attenu-
ation, pseudocyst formation, accumulation of absorption
droplets, sometimes “microvillous transformation”) fol-
lowed finally by detachment [39–41].
These events cause a continuous loss of podocytes
and, frequently together with an hypertrophic growth of
the tuft, lead to a decrease in podocyte density which
is seen under various circumstances [13, 16, 20, 42–45].
Since podocytes in the adult are incapable of regenera-
tive cell replication, lost podocytes cannot be replaced by
new cells [19, 42, 46]. The hypertrophy of the remaining
podocytes is the only way to maintain the integrity of the
filtration barrier. The additional workload on these cells
increases their vulnerability; a vicious circle is initiated.
The podocytes eventually are too few to maintain a
complete cover of the tuft. Naked areas of GBM occur, to
which parietal epithelial cells can adhere. Such a parietal
cell bridge goes necessarily along with the formation of
a local gap within the parietal epithelium, including the
formation of naked areas of PBM. By establishing further
cell bridges between the PBM and the GBM adjacent
to the first and deposition of some matrix between the
bridging cells, finally an adhesion of the tuft to Bowman’s
capsule is established [39, 46].
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Fig. 3. Crescents.
The adherent tuft portion generally contains at least
one capillary loop that bulges with its naked (podocyte-
deprived) GBM surface toward the core of the adhesion.
As a consequence, such capillaries deliver their protein-
rich filtrate into the interstitium instead of Bowman’s
space [47, 48]. In response, interstitial fibroblasts create
a multilayered cellular patch around the focus of misdi-
rected filtration, limiting the entry of fluid into the inter-
stitium. This results in the formation of a crescent-shaped
space filled with a proteinaceous fluid overarching the ad-
hesion (proteinaceous crescent) (Fig. 3); hyaline material
also frequently accumulates within the adherent portion
of the tuft. Actually, the hyalinosis [54] inside the GBM
and the proteinaceous crescent outside are the two sides
of the same coin (i.e., of misdirected filtration through
a podocyte-deprived filtration barrier: Plasma proteins
accumulate on both sides.
As outlined in Figure 3, a nascent crescent consists
of three portions. Spreading of the proteinaceous fluid
within the middle compartment into all directions leads
to an expansion of the proteinaceous crescent on the
outer surface of the glomerulus and eventually also of
the tubule (see below). In the case that this process comes
to a standstill, frequently at the border of a lobule, a re-
pair process by scaring may lead to a synechia (i.e., to
segmental glomerulosclerosis (Fig. 4).
Inflammatory mechanisms
There are numerous types of glomerulonephritis in hu-
mans and also numerous animal models. We will not dis-
cuss specific diseases. Instead, in keeping with the subject
of this review, we will focus on the most frequent pathway
to nephron loss in glomerulonephritis (i.e., formation of
a cellular crescent).
In our presentation, we rely largely on our own
work, which, in addition to unpublished work, includes
models of anti-GBM nephritis in rats and mice, “clas-
sic” Masugi nephritis, pauci-immune-glomerulonephritis
(SCG/kj mouse) and Thy-1–mediated mesangioprolifer-
ative glomerulonephritis (see Fig. 1). We have carefully
considered studies from other investigators dealing with
histopathology of glomerulonephritis in animal models
[52, 60–65] as well as in humans [66–73].
A glomerular inflammation starts in the endocap-
illary compartment, affecting the capillaries and the
mesangium. It may take a mild course, remaining bound
within the endocapillary compartment. This is associated
with an early turn to restitution (see below). The endocap-
illary process may take an aggressive course, leading to
breaks in the GBM and exudation into Bowman’s space.
Breaks in the GBM and spreading of the inflammation
in Bowman’s space constitute a dramatic injury [49]. The
glomerulus will most likely die and the nephron be lost.
Formation of cellular crescents is probably associated
with a moderate level of severity of the inflammation
ranging in between the mild and the aggressive course
described above. The way that a crescent develops from
an endocapillary process has long been an enigma. It is
widely believed that crescents develop within Bowman’s
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Fig. 4. Sclerosis, glomerulosclerosis, collapsing glomerulopathy.
space as a result of breaks in the GBM and egress of
blood borne compounds (among them fibrinogen) into
Bowman’s space [52, 62, 63]. However, in several experi-
mental studies, exudates were not conspicuous at early
stages of crescent formation [22, 25, 60, 61, 64]. Our
observations in experimental models of glomeru-
lonephritis suggest that the crucial role in crescent forma-
tion is played by epithelial cells that establish cell bridges
between the tuft and Bowman’s capsule. This is in agree-
ment with many studies in humans and in experimental
animals, showing that early crescents include cells of ep-
ithelial origin (see below).
An endocapillary inflammation induces a stereotyped
pattern of morphologic alterations in podocytes. Most of
these changes are frequent in noninflammatory diseases
as well: simplification of foot processes, focal detachment
from the basement membrane, increased incidence of in-
tracellular vacuoles, and microvilli-like microprotrusions.
The most specific feature of inflammatory diseases are
coarse and irregular microprojections on the apical aspect
of the cell body. In the inflammatory models which we
have examined (see Fig. 1), this phenotype of podocytes
was associated with the formation of podocyte bridges
between the tuft and Bowman’s capsule.
Podocyte bridges are by definition made up of cells
which adhere to both the GBM and the PBM. It is
not known by which mechanism a cell process of a
podocyte gets across the parietal cell layer. It is likely that
podocyte processes disrupt the junctional complexes be-
tween two parietal cells and fix to the PBM. At the PBM,
they frequently enlarge to lamellipoda-like structures,
hereby dislodging the parietal epithelial cells [22, 25]. Fre-
quently, cells adjacent to a podocyte bridge develop fur-
ther bridges, including those of parietal epithelial cells
that fix to the GBM [25]. After depositing basement
membrane-like matrix between the cells, the entire bridg-
ing structure interconnecting the GBM and the PBM rep-
resents a tuft adhesion to Bowman’s capsule.
The altered location of both types of glomerular
epithelial cells together with loss of usual junctional
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Fig. 5. Transfer of a glomerular injury onto the tubulointerstitium.
connections [22] obviously profoundly alters their behav-
ior. They proliferate and spread, resulting in the forma-
tion of a cellular crescent. It is noteworthy that the spread-
ing of crescent cells takes place inside the PBM, but out-
side a more or less well preserved parietal epithelium,
thus (like in a proteinaceous crescent, discussed above)
in a newly emerging space between the parietal epithe-
lium and its basement membrane; this portion represents
the crescent proper (Fig. 3). Apart from the connecting
stalk between the tuft and the crescent, a narrow uri-
nary space subsists between the crescent and the tuft. Of
note, this feature is visible only in perfusion-fixed kid-
neys. Since the starting point for crescent formation is a
podocyte bridge between a capillary loop and the PBM,
it is not surprising to find at least one capillary loop in-
cluded in the adherent tuft portion of every crescent. In
an advanced stage, these loops are generally hyalinized,
but perfused capillaries may also be found that obviously
deliver their filtrate into the crescent. Thus, by the same
mechanism as described above in degenerative models,
proteinaceaous crescents may be formed in inflammatory
models as well. Mixed crescents (cellular/proteinaceous)
are frequent.
Young crescents contain mainly epithelial cells as seen
in animal models [22, 60, 61, 64], as well as in humans [66,
68, 70–74]. As shown recently, a significant fraction of
epithelial cells in crescents are derived from podocytes
[64, 75], which, during their displacement and prolif-
eration, have lost all specific podocyte markers. This
phenotype represents, in addition to collapsing glomeru-
lopathy, another example of the proliferative ability of
dedifferentiated podocytes. Podocytes contribute only to
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a fraction of the epithelial cells of a crescent [75]. The rest
probably emerges from proliferation of parietal epithe-
lial cells as already suggested in older work on human
glomerulonephritis [70, 73] and on a murine model [60].
In agreement with the epithelial origin of the cells, the in-
tercellular matrix of early (“cellular”) crescents consists
of an amorphous basement membrane-like material in
both human [68, 76] and murine glomerulonephritis [22]
in addition to varying proportions of proteinaceous fluid.
Macrophages are a further component of crescents
in humans [66, 68, 69, 71, 73] and in animal models
[63]. According to our observations, macrophages first
accumulate within the cap of proliferating interstitial
tissue that covers a nascent crescent from the outside
(Fig. 3). In early crescents, this interstitial reaction is
separated from the crescent proper by the intact PBM.
Later, macrophages increasingly intermingle with epithe-
lial cells within the crescent proper, most likely by inva-
sion through breaks in the PBM as shown in humans [70]
and in a model of glomerulonephritis in the rat [52].
Like with proteinaceous crescents, cellular crescents
may progress to more severe damage, eventually to
nephron loss (next chapter) or they may undergo repair
by scarring, terminating in segmental glomerulosclerosis
(Fig. 4).
TRANSFER OF A GLOMERULAR INJURY ONTO
THE TUBULOINTERSTITIUM
Glomerular damage is generally accompanied by tubu-
lointerstitial damage and there is widespread agreement
that the former causes the latter. However, there is dis-
agreement concerning the underlying mechanisms. As
summarized in the synopsis shown in Figure 5, sev-
eral mechanisms are under discussion. The most popu-
lar notion is that protein leakage in injured glomeruli
into tubular urine leads to excessive protein reabsorption
in proximal tubules, resulting in tubulointerstitial injury.
Recently, mechanisms have been uncovered that lead to
a direct encroachment of extracapillary lesions onto the
tubule via the glomerulotubular junction; they will be ad-
dressed first.
Encroachment of a glomerular injury onto the
glomerulotubular junction
Two mechanisms have been uncovered. First, there is
an extension of a proteinaceous crescent onto the outer
aspect of the proximal tubule. As a consequence of persis-
tent misdirected filtration, the proteinaceous filtrate, via
the glomerulotubular junction, expands in the space be-
tween the tubular epithelium and the tubular basement
membrane and may spread within this space along the en-
tire proximal convolution. This process is predominantly
associated with degenerative glomerular diseases [47, 48],
Table 1. Crescentic glomerulonephritis in mice (N = 265 glomeruli
examined in section series)
Number Description
168 glomeruli without
crescents
Corresponding tubules show
normal structure
97 crescentic glomeruli
57 crescents do not extend in
tubular neck
Corresponding tubules show
normal structure
40 crescents obstruct the
tubular neck
Corresponding tubules show
features of degeneration
Serial section analysis of glomerulotubular connections on day 10 in the
disease [23].
but may also be found as the dominant process in indi-
vidual nephrons in inflammatory diseases [25].
The second mechanism is the encroachment of a grow-
ing cellular crescent upon the glomerulotubular junction.
Thereby the initial segment of the proximal tubule gets
incorporated into the crescent. This process is character-
istically found in inflammatory models [23, 25, 26]. How-
ever, cellular proliferation is complemented frequently
in inflammatory models by misdirected filtrate spread-
ing, leading to mixed crescents.
These two processes appear to be very frequent in ex-
perimental models under various circumstances and have
also been shown to occur in human cases [48, 77, 101]. In
a murine model of crescentic glomerulonephritis [23], the
relevance for final nephron degeneration has been quan-
tified by tracing 265 nephrons in serial sections (Table 1).
Exclusively glomeruli with crescents and among them
only those that extended onto the glomerulotubular junc-
tion were associated with tubular degeneration in vari-
ous stages (see below). In our view, this represents very
strong evidence for the concept that the tubular injury
develops by encroachment of a glomerular injury onto
the glomerulotubular junction.
Both mechanisms, abnormal filtrate spreading and cel-
lular overgrowth, may lead to the loss of the nephron. A
nephron is functionally lost when urine flow is irreversibly
impeded by tubular degeneration. The latter may occur
directly or it may be preceded by tubular atrophy (both
processes are described below in detail). Peritubular fil-
trate spreading, which is less aggressive compared to cel-
lular overgrowth, may first lead to tubular atrophy. At this
stage, the nephron is still in function and produces urine,
even though tubular functions are necessarily impaired.
Such nephrons may reach a status of some kind of re-
pair, exhibiting a segmental adherent scar at the glomeru-
lus and an atrophic portion of the proximal tubule. It
is unknown how long these nephrons may survive. As
seen in experimental models, the atrophic portion of the
tubule, sooner or later, will proceed to degeneration, get
obstructed and thus irreversibly damaged (see below).
Cellular overgrowth of the glomerulotubular junction di-
rectly leads to tubular degeneration with early obstruc-
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tion generally affecting the glomerulotubular junction.
Thus the nephron is functionally lost. As intermediate
stages to complete structural loss, atubular glomeruli and
aglomerular tubular remnants are generally encountered.
The final decomposition and the removal of the tubular
remnants always occur within a short time in a steadily
progressing manner in conjunction with a local intersti-
tial inflammation, whereas the final decomposition of the
glomerular remnants may be delayed (see below). Atubu-
lar glomeruli thus represent a common finding in exper-
imental as well as human diseases [10, 14, 15, 23, 25, 48,
101–107].
Tubular atrophy begins with the loss of the brush bor-
der and the basal interdigitating cell processes, including
their mitochondria. In the end, the complex proximal ep-
ithelium is transformed into a simple flat epithelium re-
sembling the parietal epithelium of Bowman’s capsule
[25, 48, 108]. Functionally, this dramatically simplified
epithelium does not appear to be capable of perform-
ing any of the specific transports of the proximal tubular
epithelium.
Tubular degeneration starts with obstruction of the
tubule, generally at or close to the glomerulotubular junc-
tion. Deprived of a luminal load, the tubules collapse, the
cells lose their arrangement as a polarized epithelium and
transform into solid cords of polygonal cells. Lysosomal
elements accumulate; finally the cells die. The empty re-
mains of the tubular basement membrane become wrin-
kled and infiltrated with inflammatory cells. Cellular and
matrix residues are finally removed by macrophages and
replaced by fibrous tissue [23, 25, 48].
Atubular glomeruli all have a tuft-to-capsule connec-
tion. They may either collapse or develop cystic expan-
sions of Bowman’s capsule [25, 48]. Collapsed glomeruli
appear to undergo a slow (compared with that of tubules)
process of decomposition. The characteristics, podocyte
dedifferentiation with loss of the cytoskeleton, detach-
ment and disappearance of adjacent capillaries, collapse
of the “capillary-deprived” GBM, are reminiscent of
tuft degeneration in collapsing glomerulopathy [32]. Cys-
tic expansion of Bowman’s space appears to develop
in glomeruli with some ongoing filtration and in which
Bowman’s capsule does not withstand expansion. These
glomerular remnants appear to survive for long periods,
possibly lifelong [25].
The decomposition of nephron remnants induces a lo-
cal interstitial inflammation [23, 25, 48]. Inflammatory
cells immigrate and fibroblasts transform into a-smooth
muscle actin (a-SMA)-positive cells. After removal of
the nephron remnants, this proliferative tissue transforms
into fibrous tissue. From a teleologic point of view, these
processes are responsible for the removal of the nephron
remnants and for the filling of the space left by degen-
erated tubules. Since at the onset of this process the
nephron is already irreversibly damaged, in our view, this
process guarantees the preservation of an intact tissue
architecture.
Protein leakage into tubular urine
It has been proposed that continuous protein leakage
through an impaired glomerular filter into tubular urine
is not merely an indicator of severity of disease but also a
trigger of progression. The “proteinuria hypothesis” has
been the subject of many reviews [90–93, 109–113]. Sev-
eral mechanisms have been proposed as to how filtered
proteins (including protein-bound substances) may lead
to tubulointerstitial damage. Since they have been amply
presented in the above-mentioned reviews, we present a
synopsis of the various proposals (Table 4). As seen there,
they may be subdivided into (1) effects of excessive reab-
sorption and lysosomal degradation of proteins, (2) direct
effects of toxic compounds, and (3) secondary effects of
proinflammatory and profibrotic mediators produced by
tubular cells; the resulting inflammation/fibrosis is sup-
posed to be responsible for the loss of nephrons. The third
mechanism has received the broadest support so far.
In our models, we found no convincing evidence for
harmful effects of filtered proteins on tubular cells [21, 23,
25, 47]. In contrast, even in cases of severe glomerular in-
jury, the proximal tubule remained healthy in appearance
as long as the glomerular injury did not extend onto the
glomerulotubular junction (Table 1) (i.e., in cases with en-
croachment of extracapillary glomerular lesions). Since
the question as to the damaging effects of protein leakage
and interstitial inflammation presumably derived thereof
not only relates to the particular nephron with protein
leakage but also to neighboring so far healthy nephrons,
thereby becoming an autonomous factor of progression,
we will discuss this in the next section.
PROGRESSION OF THE DISEASE
The progressive decline in renal function in chronic
renal disease is underlain by the continuous loss of
nephrons, independent of whether the original disease
persists. Thus, once a certain degree of injury is estab-
lished, the disease enters into a vicious cycle. Indeed, in
most cases of chronic renal disease, the histopathologic
pattern is focal from the beginning. Severely damaged
nephrons are found close to rather normally looking ones.
It might thus be expected that a fraction of the nephrons
would maintain a stable function when the primary dis-
ease heals or is therapeutically brought under control.
However, clinical experience does not support that ex-
pectation and generally a progressive deterioration of
renal function occurs. This raises the question as to a
mechanism whereby nephron loss is deleterious to surviv-
ing nephrons. There are basically two hypotheses, over-
load and fibrosis, to explain how a damage may be passed
on from one nephron to another.
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Fibrosis hypothesis
According to this hypothesis the tubulointerstitial in-
flammation, which regularly develops in proteinuric dis-
eases in conjunction with tubular degeneration, leads to
progressive fibrosis accounting for the further deterio-
ration of renal function [81, 90–93, 109, 113, 114]. This
hypothesis was originally developed on the basis of three
observations. First, several studies showed that the de-
cline in renal function in chronic renal disease correlates
more closely with interstitial fibrosis than with glomeru-
lar damage [92, 115–120]. Second, the level of protein-
uria correlates well with the rate of progression in var-
ious diseases [91, 93, 109, 113, 121]. Third, exposure to
high concentrations of proteins induces the production of
proinflammatory and profibrotic factors by tubular cells
[91, 93, 94, 111, 122].
Accordingly, it is assumed that protein overload in a
tubule induces a local interstitial inflammation that even-
tually destroys not only that tubule but also neighboring
tubules. This assumption is essential to every discussion
about the impact of fibrosis on progression. In most pub-
lications on this subject, this question is not explicitly
raised; it is simply assumed that fibrosis is harmful. A
concrete hypothesis has never been formulated on how
fibrosis might proceed to the loss of the nephrons.
This brings us to the decisive questions on this issue:
Does the focal tubulointerstitial inflammatory process
that consistently occurs in glomerular diseases initiate
nephron destruction? Is there a start of nephron destruc-
tion in the tubulointerstitium?
The answer from all our studies of degenerative as
well as inflammatory models of nephron degeneration
is clearly “no.” An interstitial inflammation was only en-
countered in conjunction with the degeneration and re-
moval of an already irreversibly damaged nephron [23,
25, 123]. By tracing in serial sections, it became obvious
that tubular segments of healthy nephrons, even if fully
surrounded by degenerating tubules of neighboring af-
fected nephrons, preserved their usual features of a dif-
ferentiated, normally functioning epithelium [12, 23, 25].
Thus, we found no evidence of progression of the disease
at the level of the tubulointerstitium. On the contrary,
by removing the remnants of nephrons and by replacing
them with scars, the interstitial reaction assures that the
degenerative mechanisms remain confined to the affected
nephron.
This conclusion agrees with experimental studies aim-
ing at directly testing the effect of proteinuria and
of proteinuria-induced interstitial inflammation on the
progression of renal failure. Daily injections of bovine
serum albumin for at least 1 week provokes a promi-
nent diffuse infiltration of the peritubular interstitium
with macrophages and lymphocytes [91, 124–126]. How-
ever, neither nephron loss nor a progressive reduction of
renal function have been demonstrated in those studies.
Adriamycin nephropathy induced in analbuminemic rats
compared to wild-type rats [127, 128] did not show any
difference between the two strains. In spite of a massive
decrease in total proteinuria and of the lack of urinary
albumin in mutant rats, the morphology of the tubuloin-
testitium and the decrease in inulin clearance were not
different between the two groups. This shows that tubu-
lar albumin is not a critical factor in producing the tubu-
lointerstitial alterations in that model but, surely, does
not rule out a specific pathogenetic role of some other
proteins. The preservation of renal function in minimal
change nephropathy in human as well as in several exper-
imental studies mimicking this disease [14, 15, 126] speak
against a major impact of proteinuria per se on the tubu-
lointerstitial disease. In one of these models, namely in
adriamycin nephropathy [14], the stage of pure minimal
change nephropathy was followed, without significant in-
crease in the degree of proteinuria, by the development
of FSGS. Only at that stage, nephron loss, focal intersti-
tial inflammation around the degenerating tubules and
deterioration of renal function occurred. Serial sections
revealed an association between the tubular degenera-
tion and the encroachment of the extracapillary lesion
onto the glomerulotubular junction.
The evidence supporting a crucial contribution of pro-
tein leakage and of the subsequent interstitial reaction to
progression is correlative in nature. It is grounded on two
well-documented sets of clinical data. First, a correlation
exists between the amount of excreted proteins and the
pace of disease progression [109, 113, 121, 129]. How-
ever, the degree of glomerular damage is a confounding
factor in that correlation: The more severe the glomeru-
lar injury, the higher the level of proteinuria but also the
risk that glomerular damage directly encroaches upon
the tubule and leads to nephron degeneration. Second,
the decline in renal function in chronic renal failure cor-
relates more closely with interstitial fibrosis than with
glomerular damage (see above). This fact is taken as ar-
gument in favor of a genuine interstitial mechanism of
progression. Thereby one overlooks a crucial fact: As
animal models (see above) and studies in the aging hu-
man kidney show [130, 131], the remnants of a degen-
erative nephron, including glomeruli, may be completely
removed and replaced by fibrous tissue. Thus, with the de-
generation of nephrons, the interstitial damage score will
increase, while the glomerular damage score will remain
constant or even decrease due to complete disappearance
of sclerotic glomeruli. Recent studies clearly show that
the decline in renal function in chronic renal disease cor-
relates best with the number of remaining nephrons [132].
Taken together, the correlations between proteinuria and
interstitial fibrosis on the one hand and progression of
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the disease on the other do not allow any conclusion
as to the pathways along which the nephron underwent
destruction. Thus, the evidence for the fibrosis hypothesis
is far from being conclusive.
Overload hypothesis
The core of this hypothesis reads as follows. Loss of
nephrons leads to a work overload on the remaining
nephrons followed by compensatory mechanisms (i.e., by
hypertrophy), in particular by glomeruli exposing them
to hypertension resulting in hyperfiltration and protein
leakage. This leads sooner or later to glomerular damage
that, according to the degenerative pathway to sclerosis
discussed above, may proceed to nephron loss, thus clos-
ing a vicious cycle based on nephron loss [133–138].
The validity of this hypothesis has been repeatedly
confirmed in the model of nephron mass reduction by
nephrectomy or infarction. In several of those studies,
systemic blood pressure as well as intraglomerular blood
pressure were manipulated by various means. Depend-
ing on the protocol, the remnant nephrons compensated
partially or fully for the decrease of nephron number
by increasing single nephron GFR. Thereby, the intra-
glomerular blood pressure rose and glomerular hyper-
trophy was initiated. On the long run, a deterioration
of renal function and development of glomerulosclerosis
were observed. Intraglomerular blood pressure appears
to be the main pathogenic trigger in this model [55, 133,
136, 139, 140], but a contribution of glomerular hypertro-
phy is likely [42, 135, 138, 141–143]. Thus, the evidence
supporting the overload hypothesis is strong. However,
many details are insufficiently understood, in particular
the regulatory routes along which the compensatory hy-
perfunctions are elicited as well as how glomerular hy-
pertension translates into protein leakage and glomerular
damage [144].
In animal models, the hypertensive injury is specific;
it consists of the vascular pole associated glomeruloscle-
rosis that develops from a pressure dependent dilation
of the first branches of the glomerular afferent arte-
riole [10, 145]. This suggests that the initiating failure
consists of the incapability of the vessel wall to develop
sufficient counterforces. Numerous studies [9, 146–148]
support the notion that indeed the failure of podocytes
to generate sufficient counterforces in response to high
capillary pressure accounts for the start of sclerosis devel-
opment. Under such conditions, podocytes up-regulate
several genes, including osteopontin, which is known to
be elevated in glomeruli in vivo in the deoxycorticosteroe
acetate (DOCA)-salt model associated with glomerular
hypertension [149]. Podocytes have stretch-sensitive ion
channels and may respond along Ca++ dependent and
independent signaling routes [150]. Podocytes have an-
giotensin II type 1(AT1) receptors [151] that become up-
regulated in response to stress [152]. Increased signaling
via AT1 receptors is damaging to the podocyte, resulting
in protein leakage and finally in sclerosis [21].
In addition to the mechanical challenge itself, there is
increasing evidence that the enhanced passage of plasma
proteins across the filtration barrier associated with
glomerular hypertension may be harmful to podocytes
themselves. A certain proportion of proteins passing
through the filter is generally taken up by podocytes,
more precisely at their basal aspect by the foot processes
[153, 154]. Excessive amounts may lead to an overtax-
ing of the lysosomal system with the deleterious conse-
quences generally attributed to the proximal tubule cells
under these circumstances (i.e., spillage of lysosomal en-
zymes into the cytoplasm and increased production of
reactive oxygen species, proinflammatory and profibrotic
mediators). Note that in contrast to proximal tubule cells
whose regenerative potential is great, podocytes are in-
capable of cell regeneration. Evidence that those mech-
anisms may play a role with respect to podocyte loss
has been presented in several studies [12, 24, 96, 155].
Thus, the cells whose failure is responsible for the in-
creased leakiness are challenged by the consequences
(i.e., the increased accumulation of proteins within the
filter). Consequently, proteinuria, as suggested by cor-
relative evidence (see above), may well be a promoting
factor of progression, but by damaging podocytes rather
than by inducing fibrosis.
In conclusion, the overload hypothesis is strongly sup-
ported by a great variety of experimental studies. In
contrast, the evidence that fibrosis is responsible for pro-
gression is meager. It should be noted that the two mech-
anisms are not mutually exclusive, they may be additive.
REGENERATION AND REPAIR OF
GLOMERULAR INJURIES
In recent time, the question as to the capability of a
damaged nephron to undergo regeneration (restitution of
structure and function) has been repeatedly raised [156–
159]. What are the chances for therapeutic interventions?
Is it possible to define a point of no return, a certain de-
gree of damage that inevitably will proceed to loss of the
nephron?
There are very few studies which have thoroughly ad-
dressed these questions. Therefore, we may only present
some examples from individual models. They clearly
show that the possibilities to repair a glomerular dam-
age are quite limited.
Again, it is useful to distinguish between endo- and
extracapillary lesions. As long as an injury remains bound
within the endocapillary compartment, the injury may
undergo regeneration (complete restitution) or it may
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be repaired, leaving behind a mesangial scar (mesangial
sclerosis). An extracapillary lesion associated with a tuft
adhesion no longer has a chance to regenerate; the only
chance for healing is the formation of an adherent scar.
Endocapillary injuries
The capacity of endocapillary lesions to be repaired is
enormous. This is exemplified in Thy-1 nephritis, in the
case of a severe endocapillary injury with an almost com-
plete loss of capillaries and of mesangial cells, leading
to the formation of a mesangial balloon. The repair fol-
lowed a strict sequence [25] which, to some extent, mimics
the development of a glomerular lobule during ontogeny,
necessitating the orchestration of several regulatory cir-
cuits [160–168]. In this sequence in the first stage, new
capillaries sprout up to sites beneath the GBM, proba-
bly attracted by podocytes. In the second stage, a-SMA–
positive cells (derived from cells in the extraglomerular
mesangium [169]) gather around capillaries and estab-
lish connections to the GBM in between the capillar-
ies as well as to other centrally located mesangial cells;
all together these a-SMA–positive cells form an inter-
connecting network fixed to the GBM and to the extra-
glomerular mesangial cells at the vascular pole. In the
third stage, centripetal contraction of this network results
in the reestablishment of GBM infoldings separating in-
dividual capillaries, thus providing a lobular texture that
allows filtration. The accumulation of mesangial cells and
matrix in the center of such a reestablished “lobule” rep-
resents the supporting core; it may become reduced in
volume by a comparably slow remodeling process [159,
163], nevertheless, a mesangial scar (mesangial sclero-
sis) remains. This process is remarkable; it ensures the
reestablishment of a glomerular lobule with a proper
higher order structure (i.e., with peripherally arranged
capillaries supported by centrally located mesangial tis-
sue). The temporal and spatial sequence of these events
appears to prevent excessive mesangial cell proliferation
and matrix deposition.
In less severe endocapillary damage without loss
of capillaries, repair may start earlier at the second
stage [25]; proliferation and subsequent contraction of
a-SMA–positive cells (like in wound closure [170]),
thereby reestablishing a folding pattern of the GBM,
represent indispensable steps in every repair of an en-
docapillary injury. No data are available about whether a
mesangial aneurysm with egress of blood into the mesan-
gial space may enter a repair process and if yes when,
then how this occurs.
Extracapillary injuries
The most characteristic feature of extracapillary le-
sions consists of formation of connections between the
tuft and Bowman’s capsule. This includes (1) simple
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Fig. 6. Flow diagram of damage progression in degenerative and in-
flammatory glomerular diseases (does not include collapsing glomeru-
lopathy). A question mark adjacent to an arrow indicates the thate ef-
fect is not firmly established. The most direct path to nephron loss leads
from podocyte injury to crescents, to encroachment onto the tubule,
to atubular glomeruli and glomerular tubular remnants. Degeneration
of these nephron remnants leads to an interstitial inflammation whose
impact as a damaging factor is debated.
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cellular bridges between the GBM and the PBM
(podocytes and parietal cells), (2) tuft adhesions defined
in that, in addition to cells, a matrix bridge has developed,
and (3) tuft adhesions associated with different kinds of
crescents (note, that there are no crescents without a con-
necting stalk to the tuft).
Even if there is no firm proof, it is plausible that, in
the case that a disease process comes to an early halt,
simple cell bridges may resolve. This would lead to the
reestablishment of a freely floating tuft.
Based on observations in human biopsies, it has been
claimed that glomeruli with crescents may actually re-
generate [171, 172]. It was found that the incidence of
glomeruli with crescents between successive biopsies had
decreased. Such data should be interpreted cautiously for
the following reasons. First, the sample under analysis
may not be representative for the whole kidney. Second,
a fraction of crescentic glomeruli may have died and may
have been replaced by a scar between samplings. Experi-
mental data from animal models do not provide evidence
that a tuft adhesion (with or without crescent), once es-
tablished, may disconnect, reestablishing a freely floating
tuft. A tuft adhesion may become smaller and, in random
sections, it might appear that, after a certain time of re-
covery, there are fewer tuft adhesions. Quantification in
serial sections, however, clearly show that the number of
adhesions does not decrease [25].
There is agreement between observations in human
material and animal studies that crescents may undergo
a repair process terminating in an adherent scar. First,
as well known from human biopsies and autopsies, ag-
ing crescents become fibrocellular and eventually fibrous.
Breaks in the PBM allow a direct passage of cells, among
them macrophages and fibroblasts from the interstitium
into the crescent. Fibrosis in the crescent is probably, to
a large extent, the consequence of invasion of both cell
types [50, 52, 70]. There is evidence that the epithelial
cells of crescents acquire some properties of fibroblasts,
including the ability to synthesize collagen type I [74, 173,
174]. The repair of a crescent by fibrosis leads to an adher-
ent scar [25, 175] (i.e., to segmental glomerulosclerosis)
(Fig. 4). From animal models, we have some evidence that
such a repair process consists of formation of a bridge
of scar tissue that develops from both sides, from the
mesangium and the interstitium, finally interconnecting
the mesangium with the interstitium [25].
Taken together, our knowledge on the healing of
glomerular lesions is very limited. So far, it is impossi-
ble to define a specific lesion that inevitably will proceed
to the loss of the nephron. In the case that a crescent ex-
tends on the glomerulotubular junction, the chances for
any repair become small. Dramatic developments like a
glomerular destruction with uncontrolled bleeding into
Bowman’s space as frequently encountered in rapidly
progressing crescentic glomerulonephritis or disconnec-
tion of the tubule from its glomerulus, as described above,
do not appear to have a chance to repair; these nephrons
are lost forever.
CONCLUSION
We present a flow diagram showing the major pathways
discussed in this review (Fig. 6).
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